Electroceuticals/Bioelectric Medicine Market worth 25.20 Billion USD by 2021 The report "Electroceuticals/Bioelectric Medicine Market by Product (Pacemakers, Cochlear Implants, Spinal Cord Stimulators), by Type of Device (Implantable, Non-Invasive), by Application (Arrhythmia, Depression, Migraine), by End User (Hospitals) - Forecast to 2021", This report studies the global electroceuticals/bioelectric medicine market for the forecast period of 2016 to 2021. This market is expected to reach USD 25.20 Billion by 2021 from USD 17.20 Billion in 2016, at a CAGR of 7.9%. http://www.marketsandmarkets.com/Market-Reports/electroceutical-market-222053956.html
A number of factors such as rising geriatric population, regulatory approval for new and advanced electroceuticals, growing investments and funds for the development of novel therapies and electroceuticals, rising prevalence of neurological disorders, and growing prevalence of hearing loss are expected to drive the growth of the electroceuticals/bioelectric medicine market during the forecast period. In this report, the global electroceuticals/bioelectric medicine market is segmented on the basis of product, type of device, application, end user, and region. Based on product, the electroceuticals/bioelectric medicine market is categorized into implantable cardioverter defibrillators, cardiac pacemakers, spinal cord stimulators, cochlear implants, deep brain stimulators, transcutaneous electrical nerve stimulators, vagus nerve stimulators, sacral nerve stimulators, retinal implants, and other electrical stimulators (gastric electrical stimulators, transcranial magnetic stimulators, and respiratory electrical stimulators). The implantable cardioverter defibrillators segment is expected to account for the largest share of the electroceuticals/bioelectric medicine market in 2016. However, the retinal implants segment is projected to grow at the highest CAGR during the forecast period. Based on type of device, the electroceuticals/bioelectric medicine market is segmented into implantable electroceutical devices, and non-invasive electroceutical devices. The implantable electroceutical devices segment is expected to account for the largest share of the market in 2016; while, the non-invasive electroceutical devices segment is projected to grow at the highest CAGR in the forecast period. Based on application, the electroceuticals/bioelectric medicine market is segmented into product wise such as cardiac pacemakers and implantable cardioverter defibrillators (used for arrhythmia), cochlear implants (used for sensorineural hearing loss), retinal implants (used for retinal pigmentosa), spinal cord stimulators (used for chronic pain, failed back surgery, and ischemia), deep brain stimulators (used for Parkinsons disease, tremors, depression, and others), sacral nerve stimulators (used for urine incontinence and fecal incontinence), vagus nerve stimulators (used for epilepsy and other conditions), transcutaneous electrical nerve stimulators (used for treatment-resistant depression and others), and other electric stimulators (used for gastro paresis, obesity, depression, migraine headaches, and spinal cord injuries). Prominent players in the global electroceuticals/bioelectric medicine market include Medtronic plc (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Limited (Australia), Sonova Holding AG (Switzerland), LivaNova PLC (U.K.), Biotronik (Germany), Nevro Corporation (U.S.), Second Sight Medical Products, Inc. (U.S.), and ElectroCore LLC (U.S.).
About MarketsandMarkets MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model â€“ GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. M&Mâ€™s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. Contact: MarketsandMarkets 701 Pike Street Suite 2175, Seattle, WA 98101, United States Telephone No : 1-888-600-6441 Email: email@example.com
Published on Jan 12, 2017
A number of factors such as rising geriatric population, regulatory approval for new and advanced electroceuticals, growing investments and...